Phase change inks comprising a phase change ink carrier and one or more curable trans-1,2-cyclohexane bis[urea-urethane] compounds of the formulae ##STR00001## wherein R.sub.1 and R'.sub.1 are alkylene, arylene, arylalkylene, or alkylarylene groups, R.sub.2 and R'.sub.2 are alkyl, aryl, arylalkyl, or alkylaryl groups, R.sub.3 and R'.sub.3 are hydrogen atoms or alkyl groups, R.sub.4 and R'.sub.4 are hydrogen atoms, fluorine atoms, alkyl groups, or phenyl groups, n is an integer of 0, 1, 2, 3, or 4, and R.sub.5 is an alkyl, aryl, arylalkyl, or alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group, provided that at least one of R.sub.1, R'.sub.1, R.sub.2, R'.sub.2, R.sub.3, R'.sub.3, R.sub.4, R'.sub.4, or one or more of R.sub.5 is an alkyl, alkylene, arylalkyl, arylalkylene, alkylaryl, or alkylarylene group containing an ethylenic unsaturation rendering the compound curable upon exposure to heat and/or actinic radiation.